Singapore Cancer Society
How Your Donation Makes a Difference
The Singapore Cancer Society (SCS) was established in 1964 by individuals from the Rotary Club of Singapore West, the Lions Club and Jaycees, and was inaugurated by the then Minster of Health, Mr Yong Nyuk Lin.
Registered as a society in 1984 and accorded IPC (Institution of a Public Character) status as a charity in 1995 by the Ministry of Health, the Society is also a member of the National Council of Social Service and the Singapore Hospice Council. SCS celebrated 50 years of service in 2014. Being self-funded, the Society is heavily dependent on public donations to provide quality services to cancer patients, their families, and members of the public.
To be the leading charitable cancer organisation in Singapore and the region, with a reputation for effective programmes for the prevention and control of cancer.
Singapore Cancer Society is a community-based voluntary welfare organisation dedicated to maximising life by minimising the impact of cancer through research and advocacy, public education, screening, financial assistance, patient services and support, and rehabilitation.
To be the first port of call for the entire cancer journey for all cancer patients in Singapore, especially those who are financially disadvantaged.
The Society helps more than 1,800 needy cancer patients and reaches out to more than 95,000 individuals in our community outreach programmes to encourage screening and early detection of cancers.
Since its launch in April 2005, the SCS Cancer Treatment Fund has disbursed $15.4 million to subsidise the costs of chemotherapy and IMRT treatment to more than 4,635 needy cancer patients.
SCS welfare patients receive assistance in the form of financial aid and medical supplies such as milk feeds and stoma bags to help them tide over the difficult periods in their lives.
Each year, SCS needs about $21 million to run its programmes and services. Your donation will go a long way to assist our beneficiaries, giving them hope for the future.